My contribution to a board
I would help directors examine the evidence behind a digital product claim and the point at which management considers it sufficient for customer use. My experience includes a source-preservation failure in a workflow I endorsed, an image-export review and an experimental assistant that remained unreleased. Those cases show why a successful demonstration, improved test count or completed spending programme may still leave the proposed claim unsupported. A board should understand the limitation, the decision owner and the consequence of proceeding or holding. I would bring that perspective alongside commercial, financial and sector expertise, not present engineering as the whole explanation of the enterprise. The receiving company needs its own qualified product and technical specialists. My contribution should improve collective judgement while leaving implementation, everyday acceptance and the management of individual engineers with the executives responsible for them.
My first year on a board
I would use an agreed induction to understand how the receiving enterprise turns technical evidence into a product promise. With the chair’s support, I would follow one released service into its later review and one proposal still awaiting a decision. I would ask who can challenge the acceptance claim, how unresolved results reach directors and whether a stopped experiment can be reported honestly. Twenty-four annual days are an initial capacity proposal rather than a claim that every eventuality fits a fixed allowance. Preparation, committee work, travel and exceptional events need explicit discussion. I would seek feedback on whether my questions improve the board’s judgement or draw it into managing a release. A useful first-year contribution might make a limitation visible before another investment depends on it. I would learn the enterprise’s financial and sector constraints from other directors rather than assume that my current retailer’s approach should be copied.
Conflicts and their management
My executive role gives access to product plans, engineering limitations, supplier arrangements and the commercial priorities of Delqerni’s founders, investment partner and employee owners. A proposed outside appointment needs assessment of links involving those parties, equipment suppliers, technology providers and competitors. I would disclose relevant relationships before receiving restricted information and obtain appropriate advice on eligibility, independence and committee participation. No personal equity does not remove the interests created by employment and confidential knowledge. I would not transfer our unreleased product findings into another company’s strategy or use its technical weaknesses to improve my employer’s position. A recusal may address one item, but frequent exclusion from the central product decisions could undermine the contribution being sought. Capacity and any necessary employer consent also require agreement. I would decline a role that depends on privileged access or leaves me carrying an operating obligation incompatible with my executive responsibilities.
My independence statement
Employment, technical knowledge and commercial relationships require review even though I hold no shares or statutory seat. The receiving company must assess independence and suitability for its actual appointment.
Judgement in practice
01A successful edit had removed evidence needed for another decision
The synthetic crop rehearsal showed twenty-four overwritten working sources among sixty files. Separate pristine test copies remained, but the proposed workflow had still removed the next editor’s starting point. I would ask a board whether management’s acceptance account describes what a product operation preserves as well as what it produces. Directors should also know that I supported the earlier review. The later seventy-two-test account had sixty-one passing results and eleven held results, not a universal claim about content safety. Oversight should examine the meaning of the release recommendation and the responsibility for remaining work. It should not require directors to select a storage implementation or approve individual editing commands.
02An improved answer count did not justify a customer launch
The assistant experiment’s replay reduced unsupported answers from forty-two to ten within the same three-hundred-question set. I would ask directors whether the investment account distinguishes an improvement on repeated material from evidence on unseen use. The assistant remained held from customer release, and the programme did not create a measured financial return merely because the second count was lower. A board should understand which promise is proposed, who judges its support and what further evidence is needed. My contribution would challenge the inference without asking directors to become prompt reviewers. Product specialists and engineering managers retain the evaluation work, while the board examines the risk and accountability of the proposed commitment.
Committee contribution
Chair and member readiness| Capacity | Committees |
|---|
| Ready to join | Product-technology risk · Development investment oversight |
|---|
Capacity and preferences
- Time available
- 24 days per year
- Current directorships
- 0
- Sectors
- Specialist consumer retail · Customer-facing product and service businesses
- Company type
- A consumer enterprise with an experienced chair and distinct executive product and technology owners
- Company stage
- Reviewing digital product guidance or moving an experimental service towards customers
The seat I am pursuing
I would consider one first non-executive appointment in a consumer business seeking more careful challenge of product-technology claims and development commitments. An experienced chair should explain how that contribution complements the board’s existing commercial, financial and sector knowledge. After further preparation, I would initially contribute as a member of an appropriate product-risk or investment discussion, without claiming immediate readiness to chair a statutory committee. The receiving company must assess the real role and its applicable requirements. I would welcome questions about what a demonstration establishes, how an experiment remains bounded and whether management can report a stop decision without disguising it as a launch. I would avoid an appointment that expects me to approve individual code changes, select every technical method or serve as a second CTO. Collective oversight should become better informed, not turn into another engineering management chain.
Board and committee exposure
Presented to the Board or a committee
Delqerni Camera Retail
Invited product-technology and development-investment reviews
April 2023–present
Presents engineering choices and limits of product demonstrations as CTO; no statutory directorship or committee seat.
Governance learning and readiness
IICA Independent Directors’ Databank: Not yet registered
Governance preparation and registration for a prospective first independent appointment are unfinished. Executive investment presentations do not constitute director service.
- Studying how directors challenge product claims without taking over release management
- Preparing to assess committee responsibilities and relationships involving technology and product partners